Differentiate yourself from the competition.

Allostatix Risk Prediction System (ARPS™) is the first health measurement tool to predict the likelihood of disease, three to five years in advance, with up to a 90% accuracy. Headquartered in Cincinnati, Ohio, Allostatix uses neural networks to transform longitudinal health data into accurate, actionable knowledge for you and your clients.

Allostatix technology empowers you to consult your clients on effective benefit structure decisions to reduce overall medical costs and optimize their wellness programs. When using the ARPS™ platform in conjunction with existing wellness programs, your client can expect a $8.6:1 ROI over 3-5 years, based on avoided cardiovascular and metabolic disease costs.

What that means for you is that Allostatix can differentiate your company from the competition by providing the next generation health risk tool to your clients. How? Our analysis tool identifies 12.1% more 18-45 year old individuals at risk for illness and disease, than a traditional HRA. As you know, it is well documented that this age group will be your client’s largest health cost driver in the near future.

Allostatix is looking for distributors.

If you are interested in becoming an Allostatix distributor, please contact Jane Young at jyoung@allostatix.com for more information.